<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) is a highly aggressive non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, composed of a monomorphic population of medium-sized B cells with a high proliferation rate and a consistent MYC translocation </plain></SENT>
<SENT sid="1" pm="."><plain>Epstein-Barr virus (EBV) has been associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> with different frequencies depending on the clinical variant </plain></SENT>
<SENT sid="2" pm="."><plain>Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo>-associated herpesvirus, or human herpesvirus 8 (HHV-8), infects a wide range of <z:mpath ids='MPATH_458'>normal</z:mpath> cells, having a well-established role in the pathogenesis of various <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, including Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo>, primary effusion <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, multicentric <z:e sem="disease" ids="C0017531" disease_type="Disease or Syndrome" abbrv="GLNH|AFLH">Castleman disease</z:e> (MCD) and MCD-associated plasmablastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In secondary <z:hpo ids='HP_0002721'>immunodeficiencies</z:hpo>, such as HIV-1 infection and organ transplantation, HHV-8 is considered an opportunistic pathogen linked to the development of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> and HIV + patients </plain></SENT>
<SENT sid="4" pm="."><plain>We studied the association of EBV and HHV-8 by immunohistochemical analysis, in situ hybridization, and polymerase chain reaction in a large number of well-characterized <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>EBV was present in 45.0% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cases with higher incidence in the pediatric group; most cases were EBV type A </plain></SENT>
<SENT sid="6" pm="."><plain>We found no association of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> with HHV-8 in EBV + <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> or in EBV-cases, including the HIV + <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> group </plain></SENT>
</text></document>